Ticagrelore Alone Post PCI

PHASE4RecruitingINTERVENTIONAL
Enrollment

5,400

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

May 1, 2026

Conditions
Coronary Artery Disease
Interventions
DRUG

aspirin 80 mg and clopidogrel 75 mg daily

post PCI patients received these two drugs as dual antiplatelet regimen

DRUG

Ticagrelor 90 MG

Post PCI patients receive Ticagrelor 90 mg two times daily as single potent antiplatelet

Trial Locations (2)

51318

RECRUITING

Cardiology Ward Shiraz University of Medical Sciences, Shiraz

7134814336

RECRUITING

professor Kojuroi cardiology clinic, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT06509893 - Ticagrelore Alone Post PCI | Biotech Hunter | Biotech Hunter